17 reports

  • Glycoprotein 41 (gp41) - Drug Profiles
  • Glycoprotein 41 (gp41) - Therapeutics Development
  • Glycoprotein
  • United States
  • World
  • Product Initiative
  • Mymetics Corporation
  • Respiratory Syncytial Virus Attachment Glycoprotein (RSV G or G) - Therapeutics Assessment
  • Respiratory Syncytial Virus Attachment Glycoprotein (RSV G or G) - Dormant Products
  • Glycoprotein
  • United States
  • World
  • Product Initiative
  • Agilvax, Inc.
  • HUMAN CYTOMEGALOVIRUS ENVELOPE GLYCOPROTEIN B (GB) - OVERVIEW
  • HUMAN CYTOMEGALOVIRUS ENVELOPE GLYCOPROTEIN B (GB) - PRODUCTS UNDER DEVELOPMENT BY INDICATION
  • Glycoprotein
  • Infectious Disease
  • Vaccine
  • United States
  • Product Initiative
  • Respiratory Syncytial Virus Attachment Glycoprotein (G or RSV-G) Overview
  • Respiratory Syncytial Virus Attachment Glycoprotein (G or RSV-G) - Drug Profiles
  • Glycoprotein
  • United States
  • World
  • Product Initiative
  • Agilvax, Inc.
  • HUMAN CYTOMEGALOVIRUS ENVELOPE GLYCOPROTEIN B (GB) - OVERVIEW
  • HUMAN CYTOMEGALOVIRUS ENVELOPE GLYCOPROTEIN B (GB) - DORMANT PRODUCTS
  • Glycoprotein
  • Infectious Disease
  • Vaccine
  • United States
  • Product Initiative
  • T-Cell Surface Glycoprotein CD3 Epsilon Chain (T-Cell Surface Antigen T3/Leu-4 Epsilon Chain or CD3e) - Drug Profiles
  • T-Cell Surface Glycoprotein CD3 Epsilon Chain (T-Cell Surface Antigen T3/Leu-4 Epsilon Chain or CD3e) - Dormant Projects
  • Diabetes
  • Glycoprotein
  • United States
  • Product Initiative
  • Xencor, Inc.
  • INTEGRIN BETA 3 (PLATELET MEMBRANE GLYCOPROTEIN IIIA OR CD61 OR ITGB3) OVERVIEW
  • INTEGRIN BETA 3 (PLATELET MEMBRANE GLYCOPROTEIN IIIA OR CD61 OR ITGB3) - PIPELINE PRODUCTS GLANCE
  • Eye Disease
  • Glycoprotein
  • Hospital
  • United States
  • Product Initiative
  • T Cell Specific Surface Glycoprotein CD28 (TP44 or CD28) - Drug Profiles
  • T Cell Specific Surface Glycoprotein CD28 (TP44 or CD28) - Overview
  • Glycoprotein
  • Therapy
  • United States
  • World
  • Product Initiative
  • Pipeline by Avipero Ltd, H2 2017
  • Pipeline by Clanotech AB, H2 2017

Loss of dystrophin glycoprotein complex causes sarcolemmal instability in muscular dystrophy.

  • Glycoprotein
  • United States
  • World
  • Product Initiative
  • Strykagen Corp.
  • T Cell Specific Surface Glycoprotein CD28 (TP44 or CD28) - Drug Profiles
  • T Cell Specific Surface Glycoprotein CD28 (TP44 or CD28) - Overview
  • Biological Therapy
  • Glycoprotein
  • United States
  • World
  • Product Initiative
  • Mechanism Of Action

Loss of dystrophin glycoprotein complex causes sarcolemmal instability in muscular dystrophy.

  • Glycoprotein
  • Health Services
  • World
  • Product Initiative
  • Strykagen Corp.
  • Official Title
  • Glycoprotein
  • Monoclonal Antibody
  • Neurological Disorder
  • Therapy
  • Biogen Idec Inc.
  • T Cell Surface Glycoprotein CD4 (T Cell Surface Antigen T4/Leu 3 or CD4) - Drug Profiles
  • T Cell Surface Glycoprotein CD4 (T Cell Surface Antigen T4/Leu 3 or CD4) - Discontinued Products
  • Glycoprotein
  • Monoclonal Antibody
  • United States
  • World
  • Product Initiative

Tumor Necrosis Factor Receptor Superfamily Member ## (ACT## Antigen or TAX Transcriptionally Activated Glycoprotein ## Receptor or CD## or TNFRSF##) pipeline Target constitutes close to ## molecules.

  • Glycoprotein
  • Therapy
  • United States
  • World
  • MedImmune, LLC
  • Glycoprotein 41 (gp41) - Drug Profiles
  • Glycoprotein 41 (gp41) - Dormant Projects
  • Glycoprotein
  • France
  • United States
  • World
  • Product Initiative
  • T Cell Surface Glycoprotein CD4 (T Cell Surface Antigen T4/Leu 3 or CD4) - Dormant Products
  • T Cell Surface Glycoprotein CD4 (T Cell Surface Antigen T4/Leu 3 or CD4) - Discontinued Products
  • Glycoprotein
  • Monoclonal Antibody
  • Oncology
  • United States
  • Product Initiative
  • INTEGRIN BETA 3 (PLATELET MEMBRANE GLYCOPROTEIN IIIA OR CD61 OR ITGB3) - OVERVIEW
  • INTEGRIN BETA 3 (PLATELET MEMBRANE GLYCOPROTEIN IIIA OR CD61 OR ITGB3) - DRUG PROFILES
  • Eye Disease
  • Glycoprotein
  • Hospital
  • United States
  • Product Initiative